Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00330811 · ClinicalTrials.gov registry record

B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient

A clinical trial, sponsored by Emory University.

Completed
Registry status
87
Enrollment target

NCT00330811 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 87 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00330811 has completed, sponsored by Emory University.

COMPLETED
Registry status
87 participants
Enrollment target

Study Summary

B-type Natriuretic Peptide (BNP) is a hormone that is made by the pumping chambers of the heart. The BNP level can be measured by a blood test and is used as a marker for heart problems in adults. Deciding if a child has a heart problem or a lung problem can be very difficult, especially in infants. Several studies have demonstrated that BNP levels are elevated when children have heart disease. The overall goal of the study is to be able to prove that obtaining BNP levels in pediatric patients can be used to identify heart problems. We already know that kids with heart problems have high BNP levels (\>200pg/ml). We need to prove that children who come to the Emergency Department for non-cardiac problems still have normal BNP levels (\<100pg/ml, slightly higher in the newborn population). This will be done by comparing BNP levels with the final diagnosis made by the ED physician.

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2006-04
Est. Completion 2007-05

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00330811

The ClinicalTrials.gov registry entry for NCT00330811 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00330811 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00330811 about?

NCT00330811 is a clinical study titled "B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient". B-type Natriuretic Peptide (BNP) is a hormone that is made by the pumping chambers of the heart. The BNP level can be measured by a blood test and is used as a marker for heart problems in adults. Deciding if a child has a heart problem or a lung problem can be very difficult, especially in infants....

What is the current status of trial NCT00330811?

This trial is currently completed. The enrollment target is 87 participants. The study started on 2006-04. Estimated completion is 2007-05.

Who is sponsoring clinical trial NCT00330811?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.